Orenitram — Total revenues
United Therapeutics Orenitram — Total revenues increased by 11.9% to $135.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $120.70M to $135.60M. Over 4 years (FY 2021 to FY 2025), Orenitram — Total revenues shows an upward trend with a 12.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher patient utilization, while a decrease may signal increased competition or loss of patent exclusivity.
Detailed definition
Represents the total gross sales generated from the commercial sale of a specific pharmaceutical product used to treat p...
Peer comparison
Comparable to product-specific revenue lines in other biopharmaceutical companies, often benchmarked against total portfolio revenue.
uthr_segment_orenitram_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.20M | $85.20M | $72.30M | $82.80M | $79.00M | $87.50M | $75.80M | $88.20M | $95.10M | $92.00M | $84.10M | $106.20M | $107.10M | $113.20M | $107.80M | $120.70M | $123.90M | $131.10M | $121.20M | $135.60M |
| QoQ Change | — | +11.8% | -15.1% | +14.5% | -4.6% | +10.8% | -13.4% | +16.4% | +7.8% | -3.3% | -8.6% | +26.3% | +0.8% | +5.7% | -4.8% | +12.0% | +2.7% | +5.8% | -7.6% | +11.9% |
| YoY Change | — | — | — | — | +3.7% | +2.7% | +4.8% | +6.5% | +20.4% | +5.1% | +10.9% | +20.4% | +12.6% | +23.0% | +28.2% | +13.7% | +15.7% | +15.8% | +12.4% | +12.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's orenitram — total revenues?
- United Therapeutics (UTHR) reported orenitram — total revenues of $135.60M in Q1 2026.
- How has United Therapeutics's orenitram — total revenues changed year-over-year?
- United Therapeutics's orenitram — total revenues increased by 12.3% year-over-year, from $120.70M to $135.60M.
- What is the long-term trend for United Therapeutics's orenitram — total revenues?
- Over 4 years (2021 to 2025), United Therapeutics's orenitram — total revenues has grown at a 12.9% compound annual growth rate (CAGR), from $306.10M to $496.90M.
- What does orenitram — total revenues mean?
- The total amount of money generated from sales of a specific drug product.